THE ROLE OF IL1RL1(SST2) IN MYOCARDIAL STRESS AND NON-ADAPTIVE REMODELING DEVELOPMENT OF HIGH PHYSICAL ACTIVITY INDIVIDUALS

Madina B. Baurzhan, Nazym S. Sagandykova, Kuat Abzaliev, K.S. AKHMETOVA, М К Мусимхан, Karashash Absatarova

2024

Closed access Metadata (CSL-JSON)
DOI 10.53511/pharmkaz.2024.56.52.002
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Sudden cardiac death (SCD) remains one of the most pressing global health problems. The United States National Young Athlete WBC Registry data show a progressive increase of SCD over the past 2.5 decades, averaging 6% per year. Despite this, there are no SCD statistics in the Republic of Kazakhstan. To study the early SCD predictors is one of the urgent tasks of modern healthcare. This review discusses the modern biomarker IL1RL1(ST2) used to diagnose SCD, myocardial fibrosis, and heart failure.